Vlaamse Parkinson Liga, Parkili Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2019
NCT03808389
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Parkinson's disease patient organizations: Vlaamse Parkinson Liga, Parkili

Active Ingredients

Drugs in Other Trials (2)

autologous fecal microbiota (1 trial)

human fecal microbiota (Reybota) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2